ADMS
Adamas Pharmaceuticals
ADMS
ADMS
Delisted
ADMS was delisted on the 23rd of November, 2021.
84 hedge funds and large institutions have $207M invested in Adamas Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 38 increasing their positions, 15 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
34% less capital invested
Capital invested by funds: $316M → $207M (-$108M)
Holders
84
Holding in Top 10
3
Calls
$37K
Puts
–
Top Buyers
| 1 | +$9.71M | |
| 2 | +$9.42M | |
| 3 | +$7.86M | |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$7.83M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.98M |
Top Sellers
| 1 | -$5.19M | |
| 2 | -$4.81M | |
| 3 | -$4.01M | |
| 4 |
RFC
Russell Frank Company
Seattle,
Washington
|
-$2.4M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.84M |